ADVANCED OR METASTATIC NSCLC
Clinical trials for ADVANCED OR METASTATIC NSCLC explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OR METASTATIC NSCLC trials appear
Sign up with your email to follow new studies for ADVANCED OR METASTATIC NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough lung cancers: drug combo shows promise
Disease control OngoingThis study tests a combination of two drugs, ceralasertib and durvalumab, in adults with advanced or metastatic non-small cell lung cancer that has worsened after standard treatments like immunotherapy and chemotherapy. The goal is to see if the combination can shrink tumors and …
Matched conditions: ADVANCED OR METASTATIC NSCLC
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 17, 2026 04:27 UTC
-
New drug cocktail shows promise for tough lung cancers
Disease control OngoingThis study tests a new drug called datopotamab deruxtecan (Dato-DXd) combined with immunotherapy, with or without carboplatin, in 155 adults with advanced or metastatic non-small cell lung cancer. The goal is to see if the combination is safe and shrinks tumors. This is an early-…
Matched conditions: ADVANCED OR METASTATIC NSCLC
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 15, 2026 11:57 UTC